MarketTwits
265K subscribers
78.2K photos
2.93K videos
1.1K files
82.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

в подборках не участвуем, партнерки не практикуем, свой канал не рекламируем, менеджеры по рекламе не нужны
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#ACRS +100% Aclaris Therapeutics, Inc. - after the company reported its A-101 45% Topical Solution met all primary and secondary efficacy endpoints in pivotal Phase 3 trial for the treatment of common warts.

#TNXP +25% Tonix Pharmaceuticals Holding Corp.- after the company reported a licensing deal with Columbia University for the development of TXN-1700 for the treatment of gastric and pancreatic cancers.

#TOPS +16% Top Ships Inc.

#OPTT +14% Ocean Power Technologies, Inc. - following Q1 results. The company reported Q1 sales increased 551% from the same period last year.

#SBGL +5% Sibanye Gold Limited

#IMUX +4% Immunic, Inc.

#AEM +4% Agnico Eagle Mines Limited

#CLR +4% Continental Resources, Inc. - after climbing 21% on Monday.

#AYX +4% Alteryx, Inc.

#NEWR +3% New Relic, Inc.

#VNE +3% Veoneer, Inc.

#NVO +3% Novo Nordisk A/S - after Citigroup upgraded the company's stock from Neutral to Buy.

ВНИЗ

#CSBR -17% Champions Oncology Inc - after the company reported worse-than-expected Q1 results.

#GLW -10% Corning Incorporated - after the company cut its outlook for the year in optical communications and display technologies segments.

#BBCP -9% Concrete Pumping Holdings Inc - after the company reported downbeat results for its third quarter and issued weak FY19 sales forecast.

#FNKO -8% Funko, Inc. -after the company reported a 4 million share common stock offering via selling shareholders.

#YUMA -8% Yuma Energy, Inc. -after rising 58% on Monday.

#XLRN -7% Acceleron Pharma Inc - after the company reported that its topline results from the Phase 2 trial of ACE-083 did not receive statistically significant improvements in functional endpoints.

#KTOV -5% Kitov Pharma Ltd - after the company's F-3 showed registration for disposition of approximately 1.86 million ADS.

#SHOP -5% Shopify Inc. - after the company priced its previously announced offering of class A subordinate voting shares at $317.50 per share.

#MT -4% ArcelorMittal

#TTM -4% Tata Motors Limited

#TPIC -4% TPI Composites, Inc.

#DRQ -4% Dril-Quip, Inc. - after the company reported that its contract for Ca Rong Do project worth $82 million was terminated.

#KHC -3% The Kraft Heinz Company-3G Global Food Holdings LP reported sale of 25 million share of Kraft Heinz.
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#CRC +29% California Resources Corporation -after reporting strong Q3 earnings.

#BGNE +26% BeiGene, Ltd. -after the company announced a global strategic collaboration with Amgen for the commercialization and development in China. Amgen will buy a 20.5% stake in BeiGene for $2.7 billion in cash.

#QRVO +10% Qorvo, Inc. -after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 EPS guidance above analyst estimates and reported a $1 million buyback.

#EYPT +8% EyePoint Pharmaceuticals, Inc. - after the company disclosed that it has secured new patient access deal with Vizient for DEXYCU.

#FTNT +8% Fortinet, Inc. - after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 and FY19 EPS and sales guidance above analyst estimates.

#AXNX +7% Axonics Modulation Technologies, Inc.

#ZLAB +7% Zai Lab Limited

#MMLP +6% Martin Midstream Partners L.P.

#ACCO +6% ACCO Brands Corporation

#AYX +5% Alteryx, Inc. -after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and FY19 guidance above analyst estimates.

#BAH +5% Booz Allen Hamilton Holding Corporation - after the company reported upbeat results for its second quarter and raised its quarterly dividend from $0.23 to $0.27 per share.

#BAND +5% Bandwidth Inc.

#GTT +5% GTT Communications, Inc.

#X +4% United States Steel Corporation - after reporting upbeat Q3 results.

#NVO +4% Novo Nordisk A/S -after the company raised its 2019 sales forecast.

ВНИЗ

#ANET -27% Arista Networks, Inc. - after the company issued Q4 sales guidance below analyst estimates.

#PINS -20% Pinterest, Inc. -after the company reported worse-than-expected Q3 sales results.

#CAR -12% Avis Budget Group, Inc. - after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY19 sales guidance below analyst estimates.

#HMSY -11% HMS Holdings Corp. - after the company reported worse-than-expected Q3 sales results. The company also cut its FY19 sales guidance below analyst estimates.

#SFET -8% Safe-T Group Ltd - after the company priced its $3.5 million public offering.

#CANF -7% Can-Fite BioPharma Ltd. - after rising 12% on Thursday.

#PYX -5% Pyxus International, Inc.

#NCMI -5% National CineMedia, Inc.

#AIG -4% American International Group, Inc. - after reporting a third-quarter earnings miss.

#OLN -4% Olin Corporation

#MTZ -4% MasTec, Inc. -after reporting weak Q3 sales.
🇪🇺#NVO
Novo Nordisk стала самой дорогой компанией Европы
🇪🇺#NVO #отчетность
Novo Nordisk
GAAP EPS of DKK 5.00, revenue of DKK 58.73B;
raises FY23 sales guidance
💥🇪🇺#NVO
Рыночная капитализация Novo Nordisk превысила маркеткап Tesla - на новом препарате от ожирения
💥🇪🇺#NVO #отчетность
Novo Nordisk отчитался лучше ожиданий, продажи препарата от ожирения Wegovy выросли более чем вдвое
——————
*датская компания Novo Nordisk — стала самой дорогой в Европе, ее рыночная капитализация превысила $570 млрд, что больше всей экономики Дании
⚠️🇪🇺#NVO
Novo Nordisk после того, как конкурент Amgen (#AMGN) опубликовал обнадеживающие данные о своем препарате от ожирения
🇪🇺#NVO
Novo Nordisk
, производитель блокбастерного препарата от ожирения, планирует размещение облигаций для расширения производства
🇺🇸🇪🇺#LLY #NVO
совместный препарат от ожирения от китайской Innovent и американской Eli Lilly показывает хорошие результаты и может стать большим конкурентом для препарата блокбастера от Novo Nordisk — BBG
💥🇪🇺#NVO
акции Novo Nordisk выросли до очередного рекорда после одобрения препарата от ожирения Wegovy в Китае
⚠️🇪🇺#NVO
Байден заявил, что Novo Nordisk должен снизить цены на свои блокбастеры от ожирения и диабета Ozempic и Wegovy
⚠️🇪🇺#NVO
Novo Nordisk на новостях о том, что препарат от ожирения Eli Lilly (#LLY) приводит к более быстрому снижению веса